September 7, 2011 — LONDON(Reuters) - Britain's health costs watchdog NICE has decided to back Japanese drugmaker Takeda's bone cancer drug Mepact after re-assessing the impact of a discount on the medicine for patients in the state-funded National Health Service (NHS).

October 18, 2010 — BOSTON (Reuters) - The osteoporosis drug Forteo can regrow bone in jaws damaged by severe bone-destroying conditions called osteonecrosis and periodontitis, doctors reported on Saturday.

July 20, 2009 — NEW YORK (Reuters Health) - The results of a study confirm that girls who undergo radiation for cancer in childhood have an increased long-term risk of developing breast cancer, regardless of their age at the time of treatment.